PhamarEngine, Inc.
- Began operation in February 2003
- # of Employees: 36 (2022 Annual Report)
- Product: ONIVYDE®
- R&D Focus: Oncology
- Chairperson: Jan-Yau Hsu
- President & CEO: Hong-Ren Wang, Ph.D.
- Spokesperson: ChiHsin Chang
- HQ: Taipei, Taiwan
Latest News
-
2024-04-24
PharmaEngine announces first patient dosed in Phase I trial of PEP07 for solid tumor cancers
-
2024-03-24
ONIVYDE® obtains positive opinion from EMA's CHMP for new regimen in First-line Treatment of Metastatic PDAC
-
2024-03-18
ONIVYDE® obtains TFDA Approval for the new regimen in First-line Treatment of Metastatic PDAC